Show
Sort by
-
- Journal Article
- A1
- open access
Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma
-
Response to comment on : Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma (Respir. Med. 2020)
-
- Journal Article
- A1
- open access
Dupilumab demonstrates rapid onset of response across three type 2 inflammatory diseases
-
- Journal Article
- A1
- open access
Data mining of free-text responses : an innovative approach to analyzing patient perspectives on treatment for chronic rhinosinusitis with nasal polyps in a phase IIa proof-of-concept study for dupilumab
-
Availability of fractional exhaled nitric oxide (FeNO) and eosinophil (EOS) count data among patients with severe asthma in five European countries
(2020) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 145(2). p.AB205-AB205 -
Dupilumab improves health‐related quality of life in patients with chronic rhinosinusitis with nasal polyposis
-
Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD
-
- Journal Article
- A1
- open access
Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma
-
Dupilumab demonstrates rapid and sustained improvements in daily asthma-related symptoms in patients with uncontrolled, moderate-to-severe asthma : data from the Liberty Asthma Quest study
-
Dupilumab improves asthma control in patients with uncontrolled, moderate-to-severe asthma, regardless of exacerbation history
(2018) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. In Annals of Allergy Asthma & Immunology 121(5). p.S42-S43